CD69 and acute myeloid leukemia: In mice, there were two distinct populations of murine AML LSCs identified, with corresponding LSCs in human AML: those overexpressing the CD36 antigen that manifest increased proliferation, and those overexpressing CD69 that were capable of self-renewal and leukemia transplantation, but exhibiting decreased proliferation potential [71].